Pediatrix Medical Group Balance Sheet Health
Financial Health criteria checks 5/6
Pediatrix Medical Group has a total shareholder equity of $890.7M and total debt of $602.5M, which brings its debt-to-equity ratio to 67.6%. Its total assets and total liabilities are $2.2B and $1.3B respectively. Pediatrix Medical Group's EBIT is $234.5M making its interest coverage ratio 11.9. It has cash and short-term investments of $463.1M.
Key information
67.65%
Debt to equity ratio
US$602.51m
Debt
| Interest coverage ratio | 11.9x |
| Cash | US$463.10m |
| Equity | US$890.67m |
| Total liabilities | US$1.31b |
| Total assets | US$2.20b |
Recent financial health updates
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Dec 15
Is Pediatrix Medical Group (NYSE:MD) Using Too Much Debt?
May 22These 4 Measures Indicate That Pediatrix Medical Group (NYSE:MD) Is Using Debt Extensively
Feb 18Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden
Oct 19Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Recent updates
Pediatrix Medical Group (NYSE:MD) Is Doing The Right Things To Multiply Its Share Price
Jan 05Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Dec 15Pediatrix Medical Group's (NYSE:MD) Earnings Seem To Be Promising
Nov 10Risks To Shareholder Returns Are Elevated At These Prices For Pediatrix Medical Group, Inc. (NYSE:MD)
Jul 31
Expanding NICU And Maternal Services Will Fuel US Healthcare Growth
Expanding service offerings, improved payer mix, and strategic acquisitions are driving revenue growth, earnings stability, and reduced earnings volatility.Is Pediatrix Medical Group (NYSE:MD) Using Too Much Debt?
May 22Insufficient Growth At Pediatrix Medical Group, Inc. (NYSE:MD) Hampers Share Price
May 01These 4 Measures Indicate That Pediatrix Medical Group (NYSE:MD) Is Using Debt Extensively
Feb 18Returns At Pediatrix Medical Group (NYSE:MD) Are On The Way Up
Jan 28Pediatrix Medical Group: The Business Is Turning
Nov 18Pediatrix Medical Group, Inc. (NYSE:MD) Shares Fly 27% But Investors Aren't Buying For Growth
Nov 06Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden
Oct 19We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)
Sep 28Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified
Aug 07Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Financial Position Analysis
Short Term Liabilities: MD's short term assets ($717.2M) exceed its short term liabilities ($392.5M).
Long Term Liabilities: MD's short term assets ($717.2M) do not cover its long term liabilities ($916.2M).
Debt to Equity History and Analysis
Debt Level: MD's net debt to equity ratio (15.7%) is considered satisfactory.
Reducing Debt: MD's debt to equity ratio has reduced from 216.4% to 67.6% over the past 5 years.
Debt Coverage: MD's debt is well covered by operating cash flow (48.1%).
Interest Coverage: MD's interest payments on its debt are well covered by EBIT (11.9x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/18 17:14 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pediatrix Medical Group, Inc. is covered by 28 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Matthew Gillmor | Baird |
| Matthew Borsch | BMO Capital Markets Equity Research |